Europe · Wires & real time · MarketScreener

Hansa Biopharma AB Stock

Published by MarketScreener · France 13 h ago

Oct. 23 Hansa Biopharma Announces Idefirix Paes Late-Breaking Abstract Selected for Oral Presentation in High-Impact Clinical Trials Session At ASN Kidney Week CI ...

Read the full article on MarketScreener Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketscreener.com)

Also worth reading

TASS

Putin meets with Egyptian President al-Sisi

Anadolu Agency

European gas hits highest level since 2022, up 4.35%

Reuters Technology

China's CXMT to start advanced AI memory production despite poor yields, sources say

Reuters Commodities

Gold slips on oil-fuelled inflation fears ahead of Fed meeting

Reuters US Markets

Trump says he approves of Brazil's Flavio Bolsonaro coming to US

Fastmarkets